Novartis Eyes Fourth Approval For Cosentyx

An nr-axSpA okay will boost Swiss major's biggest seller

 
• By Kevin Grogan
Four
Cosentyx could soon be approved for four indications • Source: Shutterstock

More from Immunological

More from Therapeutic Category